A study led by the University of Michigan Cardiovascular Center shows being a woman may not increase your risk of dying from treatment for a severe heart attack.
U-M researchers and colleagues in the Michigan Cardiovascular Consortium found women who received treatment such as an angioplasty had higher unadjusted in-hospital heart attack deaths.
But these differences appear to be related to women's ages and additional health problems – not gender, says study lead author Elizabeth Jackson, M.D., M.P.H., an assistant professor of internal medicine at the U-M Health System and member of the Women's Heart Program.
"When we adjusted for factors such as age and co-morbidities like hypertension and diabetes, women had similar mortality rates at the time of the heart attack as men," says Jackson.
"But women still appear to be more likely to have a bleeding episode in the hospital that requires a transfusion or vascular complications," she says.
The five-year study published in the American Heart Journal showed that compared with men, women were older with more co-morbidities – a medical condition in addition to the primary disease – at the time of treatment.
Women account for about one-third of patients who undergo procedures such as percutaneous coronary interventions to clear the clogged arteries causing a heart attack.
Researchers examined the outcomes of 8,771 patients undergoing a procedure for an acute ST-elevation myocardial infarction, commonly known as a severe heart attack. Patients were part of the Blue Cross Blue Shield of Michigan Cardiovascular Consortium registry, a physician-led quality improvement collaborative that is supported by Blue Cross Blue Shield of Michigan and Blue Care Network.
Previous investigations using other registries have found women had higher in-hospital mortality rates than men, but recent advancements in treatment changed how doctors care for these patients and the team wanted to re-investigate with more current data, says Jackson.
"Overall, there have been tremendous improvements in the care of both men and women who suffer a heart attack, but further research on everyday patients, such as those in the registry, is needed to be able to continue improving our level of care," says Jackson.
Cardiovascular disease kills nearly twice as many women in the United States than all types of cancer, including breast cancer, according to the American Heart Association.
February is American Heart Month and several initiatives – such as the American Heart Association's annual National Wear Red Day and the new "Make the Call, Don't Miss a Beat" campaign by the U.S. Department of Health and Human Services and its Office on Women's Health – aim to bring national attention to women's heart disease.
Also this month, the American Heart Association released its updated guidelines on preventing cardiovascular disease in women and Jackson served on an expert panel that reviewed research and recommended changes.
The Cardiovascular Consortium, called BMC2, is a collaborative network of physicians at 32 Michigan hospitals that perform percutaneous coronary intervention, such as angioplasty and stents to treat patients with coronary artery diseases.
The University of Michigan has been the coordinating center for the statewide BMC2 consortium since 1997.
Additional U-M authors: Dean E. Smith, Ph.D., M.P.H.; David Share, M.D.; Paul M. Grossman, M.D.; Hitinder S. Gurm, M.D.
Other authors: Mauro Moscucci, M.D., M.B.A., University of Miami; Simon Dixon, M.B.Ch.B., William Beaumont Hospital; Adam Greenbaum, M.D., Henry Ford Hospital
Journal reference: American Heart Journal, DOI:10.1016/j.ahj.2010.09.030
Funding: Blue Cross Blue Shield of Michigan
Disclosures: Hitinder S. Gurm receives salary support from Blue Cross Blue Shield of Michigan. David Share is employed part time by Blue Cross Blue Shield of Michigan. Mauro Moscucci has received salary support from the Blue Cross Blue Shield of Michigan. None of the authors have any conflicts relevant to this study.Resources:
Heather Guenther | EurekAlert!
Diagnoses: When Are Several Opinions Better Than One?
19.07.2016 | Max-Planck-Institut für Bildungsforschung
High in calories and low in nutrients when adolescents share pictures of food online
07.04.2016 | University of Gothenburg
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy